Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BioLife Solutions Inc

BLFS
Current price
13.86 USD +0.74 USD (+5.64%)
Last closed 13.25 USD
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 596 879 360 USD
Yield for 12 month -26.67 %
Week
Month
Year
BLFS
21.11.2021 - 28.11.2021

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; ultra-low temperature mechanical freezers; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. Address: 3303 Monte Villa Parkway, Bothell, WA, United States, 98021

Analytics

WallStreet Target Price

22.14 USD

P/E ratio

Dividend Yield

Current Year

+161 759 000 USD

Last Year

+119 156 000 USD

Current Quarter

+33 328 000 USD

Last Quarter

+39 508 000 USD

Current Year

+53 822 000 USD

Last Year

+37 748 000 USD

Current Quarter

+11 649 000 USD

Last Quarter

+11 812 000 USD

Key Figures BLFS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -40 815 000 USD
Operating Margin TTM -44.64 %
PE Ratio
Return On Assets TTM -7.5 %
PEG Ratio 63.2
Return On Equity TTM -27.62 %
Wall Street Target Price 22.14 USD
Revenue TTM 154 796 992 USD
Book Value 7.58 USD
Revenue Per Share TTM 3.58 USD
Dividend Share
Quarterly Revenue Growth YOY -18.2 %
Dividend Yield
Gross Profit TTM 54 073 000 USD
Earnings Share -2.37 USD
Diluted Eps TTM -2.37 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY 640 %
Profit Margin -66.04 %

Dividend Analytics BLFS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BLFS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:14
Payout Ratio
Last Split Date 29.01.2014
Dividend Date

Stock Valuation BLFS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 250
Enterprise Value Revenue 3.8764
Price Sales TTM 3.8559
Enterprise Value EBITDA 35.393
Price Book MRQ 1.7977

Financials BLFS

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BLFS

For 52 weeks

8.92 USD 26.89 USD
50 Day MA 12.13 USD
Shares Short Prior Month 3 961 750
200 Day MA 17.52 USD
Short Ratio 6.85
Shares Short 4 142 380
Short Percent 13.28 %